{"id":"W2487481595","doi":"10.1002/clc.22562","title":"Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the <scp>TRILOGY ACS</scp> Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"AstraZeneca Schweiz; GlaxoSmithKline; Janssen Pharmaceuticals; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Duke Clinical Research Institute; Daiichi Sankyo Europe; Sanofi; American Heart Association","keywords":"Medicine; Atrial fibrillation; Cardiology; Internal medicine; Revascularization; Clopidogrel; Aspirin; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004517866,0.0005944428,0.001600543,0.0002860168,0.0003088356,0.00156786,0.0005405366,0.001083973,0.001268812],"category_scores_gemma":[0.005827461,0.0002719523,0.001939976,0.0008598599,0.0002862727,0.0007611397,0.0007766774,0.001439242,0.0001740869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003194983,"about_ca_system_score_gemma":0.0005424967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001177288,"about_ca_topic_score_gemma":0.002971291,"domain_scores_codex":[0.99806,0.001211553,0.0001930059,0.0001940253,0.0002048237,0.0001365399],"domain_scores_gemma":[0.9960776,0.001536291,0.00124826,0.0003535067,0.0002000617,0.0005843261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1734347,0.00229522,0.7556518,0.001653849,0.0241648,0.0004823644,0.0003158256,0.001291813,0.00163657,0.0008190623,0.006964581,0.03128936],"study_design_scores_gemma":[0.03962017,0.00861707,0.9229659,0.0003680608,0.01694175,0.0006791631,0.0002734456,0.003382135,0.0003159035,0.00160876,0.005129759,0.00009804271],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820242,0.01252831,0.0002950834,0.001245308,0.0001402981,0.0001253748,0.002048397,0.00001268662,0.001580424],"genre_scores_gemma":[0.9899332,0.002976698,0.0006209547,0.0007623642,0.0006074783,0.000287421,0.004404979,0.000009391067,0.0003974348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004517866,"threshold_uncertainty_score":0.02389306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05330609231790877,"score_gpt":0.3313165372568068,"score_spread":0.278010444938898,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}